Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
This grant funds research on schizophrenia and related disorders in individuals during mid- to late-life.
About this program
The R01 Clinical Trial Optional grant focuses on understanding the impact of schizophrenia and related disorders in older adults. It aims to support innovative research that explores the unique challenges and treatment options for this population. Researchers are encouraged to investigate various aspects of these disorders, including their progression, treatment efficacy, and the overall quality of life for affected individuals. This grant is intended for academic institutions, research organizations, and other entities engaged in mental health research.
Eligibility
Eligible applicants include academic institutions, research organizations, and other entities involved in mental health research.